Agenda - Investing in Life science 2025
08:00 Registration & Coffee
08:45 Welcoming remarks, BioStock
08:50 Stories that stick: Unmuting the Nordic Biotech Narrative
Philip Engell Brainin, Associate, Sound Bioventures & YVC Collective
Bita Sehat, Partner, Trill Impact
Johan Emilsson, CEO, Sprint Bioscience
David Augustsson, Head of IR & communications, Oncopeptides
Jonas Söderström, CEO, BioStock
Company presentations
09:35 OncoInvent, Øystein Soug, CEO
09:50 Lipum, Ola Sandborgh, CEO
10:05 Initiator Pharma, Claus Elsborg Olesen, CEO
10:20 Coffee & Networking
Company presentations
10:50 Xbrane Biopharma, Martin Åmark, CEO
11:05 Orexo, Nikolaj Sörensen, CEO
11:20 ExpreS2ion Biotech, Keith Alexander, CFO
11:35 BioInvent, Björn Frendéus, CSO
11:50 Lunch & Networking
13:00 The Financing Playbook: Attracting Capital in a Shifting Market
Jacob Lindberg, Head of Equity Capital Markets, Sedermera Corporate Finance
Aneesh Khokar, Equity partner, Pareto Securities
Niclas Holmberg, Head of Commercial Strategy, Vator Securities
Company presentations
13:30 Alzinova, Tord Labuda, CEO
13:45 Alligator Bioscience, Sören Bregenholt, CEO
14:00 Cantargia, Hilde Steineger, CEO
14:15 Oncopeptides, Henrik Bergentoft, CFO
14:30 Coffee & networking
Company presentations
15:00 Abarceo Pharma, Adam Bruce, CEO
15:15 Diamyd Medical, Ulf Hannelius, CEO
15:30 Fluoguide, Morten Albrechtsen, CEO
15:45 Xintela, Evy Lundgren Åkerlund, CEO
16:00 China – The new M.V.P. in Global Pharma Dealmaking
Aaron Gu, Partner, Han Kun Law Offices
Harry Li, Eurosin Capital, CEO & Managing director
Dr Xiaona Jing, X-bridge Consulting, Managing director
16:30 Concluding remarks
After work
Agenda Highlights
Stories that stick: Unmuting the Nordic Biotech Narrative
In this panel discussion, emerging entrepreneurs and visionary investors will explore how to transform complex science into powerful, investor-ready stories. Discover strategies to balance scientific rigor with persuasive storytelling, unlocking new opportunities for funding, strategic partnerships, and accelerated growth.
Philip Engell Brainin, Associate, Sound Bioventures & YVC Collective
Bita Sehat, Partner, Trill Impact
Johan Emilsson, CEO, Sprint Bioscience
David Augustsson, Head of IR & communications, Oncopeptides
Jonas Söderström, CEO, BioStock
Time on stage: 08:50
The Financing Playbook: Attracting Capital in a Shifting Market
This panel of financing experts will deliver sharp insights on the current trends; who is investing, how to position your company, and which financing strategies actually work in this challenging climate.
Jacob Lindberg, Head of Equity Capital Markets, Sedermera Corporate Finance
Aneesh Khokar, Equity partner, Pareto Securities
Niclas Holmberg, Head of Commercial Strategy, Vator Securities
Time on stage: 13:00
China – The new M.V.P. in Global Pharma Dealmaking
Join our expert panel as we explore how Chinese dealmaking is reshaping the industry, what attracts Chinese capital and partners to Europe, and how geopolitics, regulation, and competition will shape the next decade of global pharma growth.
Aaron Gu, Partner, Han Kun Law Offices
Harry Li, Eurosin Capital, CEO & Managing director
Dr Xiaona Jing, X-bridge Consulting, Managing director
Time on stage: 16:00
Learn more about the innovators at Investing in Life Science 2025
